Freeline Therapeutics Holdings plc Gains 54.99%
Wed, Jul 12, 2023 at 07:38 PM
Freeline Therapeutics Holdings plc (FRLN:NASDAQ) shot up at $5.75, representing a gain of 55%. On Wed, Jul 12, 2023, FRLN:NASDAQ touched a New 2-Week High of $5.75. From Wed, Jun 28, 2023, the stock recorded 66.67% Up Days and 90.00% Green Days
The stock spiked on Wed, Jul 12, 2023 at $8.7 with a volume of 14M+.
About Freeline Therapeutics Holdings plc (FRLN:NASDAQ)
Freeline Therapeutics Holdings PLC is a clinical-stage biotechnology company developing transformative adeno-associated virus (AAV) vector-mediated gene therapies for patients suffering from...
Top 10 Gainers:
- Petros Pharmaceuticals Inc. (PTPI:NASDAQ), 93.37%
- The NFT Gaming Company Inc. (NFTG:NASDAQ), 90.07%
- Recursion Pharmaceuticals Inc. (RXRX:NASDAQ), 78.17%
- Ault Alliance Inc Com (AULT:NYSEMKT), 60.91%
- Freeline Therapeutics Holdings plc (FRLN:NASDAQ), 54.99%
- Camber Energy, Inc. (CEI:NYSEMKT), 48.91%
- InspireMD Inc. (NSPR:NASDAQ), 46.52%
- AVROBIO, Inc. (AVRO:NASDAQ), 45.96%
- Elys Game Technology Corp. (ELYS:NASDAQ), 43.7%
- Liminal BioSciences Inc. (LMNL:NASDAQ), 40%